Clinical Trial Update: Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber [Phase 2]

View source ↗

Summary

Phase 2 trial comparing GSK256066 to placebo in allergic rhinitis patients using a pollen challenge chamber has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• GSK256066

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Seasonal, Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED